Technophage is hiring a lab technician

Technophage is hiring a lab technician

27 Mai 2021 | Careers

TechnoPhage is hiring a Laboratory Technician to support research activities and conduct laboratory tasks within a team dedicated to the research and development of new biologic medicines. Main activities: Support scientific experiments. Execute routine...
Technophage announces FDA Fast Track Designation Granted to TP-102  for the treatment of patients with infected diabetic foot ulcers caused by Pseudomonas aeruginosa, Staphylococcus aureus and/or Acinetobacter baumannii

Technophage announces FDA Fast Track Designation Granted to TP-102  for the treatment of patients with infected diabetic foot ulcers caused by Pseudomonas aeruginosa, Staphylococcus aureus and/or Acinetobacter baumannii

14 Mai 2021 | Press release

Technophage announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to TP-102, the company’s first bacteriophage cocktail, for the treatment of infected diabetic foot ulcers caused by three different bacteria (Pseudomonas...
Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

Interview to Link to Leaders by Miguel Garcia, CEO of Technophage

11 Mai 2021 | News

In the past few months, and due to the recently initiated Phase I/IIa Clinical Trial of the bacteriophage cocktail TP-102, which has been entirely developed in the company for the treatment of diabetic foot ulcers infected by Pseudomonas aeruginosa, Acinetobacter...